findmyKOL

Philippe Moreau, MD

Enriched profile

Professor of Clinical Hematology, Nantes Faculty of Medicine (appointed 2003); Head of the Hematology Department, University Hospital of Nantes (CHU de Nantes); President, International Myeloma Society · CHU de Nantes

ORCID↗NPINone on file
✓ Full profile
RegionNot on fileSpecialtyHematology / OncologyFocusMultiple Myeloma Research and Treatments+4
Active KOLLatest publication2026Online presenceNone verifiedPaymentsNot attributedNIH fundingNone on fileWhy? →

Philippe Moreau is Professor of Clinical Hematology, Nantes Faculty of Medicine (appointed 2003); Head of the Hematology Department, University Hospital of Nantes (CHU de Nantes); President, International Myeloma Society at CHU de Nantes. OpenAlex indexes 2,103 publications with 103,109 citations (h-index 153); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Philippe Moreau is Professor of Clinical Hematology, Nantes Faculty of Medicine (appointed 2003) at CHU de Nantes (Nantes University Hospital) / Nantes Université Faculty of Medicine. The public record shows 2,103 publications with 103,109 citations (h-index 153), centered on Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology. It also documents an investigator role on 8 registered clinical trials.

  • Most recent indexed publication: 2026 · Blood cancer journal
  • Top research focus: Multiple Myeloma Research and Treatments
  • 8 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Multiple Myeloma6 trialsRecurrence1 trialLeukemia (AML/ALL/CML/CLL)

Research focus

OpenAlex concept fingerprint
Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsCancer Treatment and PharmacologyPeptidase Inhibition and AnalysisChronic Lymphocytic Leukemia Research

Drugs & molecules

across trials, industry payments and publications
DexamethasoneClinical trials2Industry payments—Publications51LenalidomideClinical trials1Industry payments—Publications24BortezomibClinical trials2Industry payments—Publications19DaratumumabClinical trials1Industry payments—Publications12CarfilzomibClinical trials1Industry payments—Publications10PomalidomideClinical trials1Industry payments—Publications9IsatuximabClinical trials1Industry payments—Publications8Lenalidomide-dexamethasoneClinical trials1Industry payments—Publications5CyclophosphamideClinical trials1Industry payments—Publications1ThalidomideClinical trials1Industry payments—Publications1MelphalanClinical trials1Industry payments—Publications—Melphalan-prednisone-thalidomideClinical trials1Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
Intergroupe Francophone du MyelomeClinical trials3Industry payments—Nantes University HospitalClinical trials3Industry payments—Institut Cancerologie de l'OuestClinical trials1Industry payments—University Hospital, LilleClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
2,103publications

Distinct works indexed by OpenAlex, matched via ORCID; 77 in PubMed.

103,109citations

Total citations across indexed works.

153h-index

Hirsch index (OpenAlex). i10-index 877.

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

0NIH grants

Federally funded research awards.

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

An office address from a public listing. This research profile has no federal registry record to draw from.

Office address

CHU de Nantes, Hôtel-Dieu, 5 allée de l'Île-Gloriette, 44093 Nantes Cedex 01, France

From the cited public source.Collected 14 Oct 2026.View source ↗

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:

All 8 trial records: search, sort and filter.Explore →

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 77 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
    3,004 citations2016
    doi.org ↗
  2. 02
    Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
    2,435 citations2021
    doi.org ↗
  3. 03
    Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
    2,181 citations2015
    doi.org ↗
  4. 04
    Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
    1,434 citations2016
    doi.org ↗
  5. 05
    Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
    1,422 citations2005
    doi.org ↗
All 2,103 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • LinkedIn

    linkedin.com/posts/nantes-universite_talent-un-nantais-parmi-les-chercheurs-activity-6737710228881711104-KmEN

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Other

    healthtree.org/myeloma/community/directory/international/university-hospital-of-nantes/philippe-moreau

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthtree.org ↗
  • Other

    myelomasociety.org/officers/philippe-moreau-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myelomasociety.org ↗
  • Spotify

    healthtree.org/myeloma/community/podcasts/feb2025-podcast-bispecific-antibodies

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthtree.org ↗
  • X / Twitter

    twitter.com/vincentrk/status/1135214772373340160

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗
  • X / Twitter

    x.com/AuclairDan/status/1968299345318715484

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
  • X / Twitter

    x.com/Myeloma_Society/status/1969082837220384958

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    x.com/VincentRK/status/1204069490981588992

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
  • YouTube

    vjhemonc.com/speaker/philippe-moreau

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Steering committee member

    International Myeloma Working Group (IMWG), since 2013

    2013
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myelomasociety.org ↗
  • Chairman

    Intergroupe Francophone du Myélome (IFM)

    2009
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →themmrf.org ↗
  • President

    International Myeloma Society (IMS)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myelomasociety.org ↗
  • Co-founder and executive board / scientific council member

    L'HEMA (Nantes hematology research structure)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chu-nantes.fr ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Scientific Advisory Board member

    Multiple Myeloma Research Foundation (MMRF)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →themmrf.org ↗
  • Scientific advisor

    ONK Therapeutics

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onktherapeutics.com ↗
  • Team member

    SIRIC ILIAD Nantes Angers (Integrated Cancer Research Site)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →siric-iliad.com ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.